"sample_name"	"unique_patient_ID"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"Dstage"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"disease_specific_mortality"	"batch"	"drug_name"	"drug_treatment"	"drug_response"	"preop_drug_treatment"	"preop_drug_name"	"fu"	"bevacizumab"	"irinotecan"	"cetuximab"	"capecitabine"	"dexamethasone"	"gcsf"	"fudr"	"folfiri"	"folfox"	"leucovorin"	"mitomycin"	"platin"	"panitumumab"	"pegfilgrastim"	"raltitrexed"	"ancillary"	"chemotherapy"	"moltherapy"	"uncurated_author_metadata"
"TCGA-A6-3810-01A-01R-1022-07"	"TCGA-A6-3810"	"TCGA-A6-3810-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	62	NA	NA	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 62///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: b728e6e8-a0e4-496b-904c-6f07c12e901f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -22999///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 175///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 30///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3810///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 122.7///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 221709cd-63c8-4056-a34f-5439af646d1e///date_of_form_completion: 2010-10-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 246///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-3810-01A-01R-1022-07///unique_patient_id: TCGA-A6-3810"
"TCGA-AA-3975-01A-01R-1022-07"	"TCGA-AA-3975"	"TCGA-AA-3975-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	80	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: a9cb21d1-4c4a-4f30-ad4d-c54bed26f187///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29309///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3975///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3975-01A-01R-1022-07///unique_patient_id: TCGA-AA-3975"
"TCGA-AA-3845-01A-01R-1022-07"	"TCGA-AA-3845"	"TCGA-AA-3845-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	86	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 86///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: bc02f801-081b-489b-87cb-d275c70299d5///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -31593///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3845///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3845-01A-01R-1022-07///unique_patient_id: TCGA-AA-3845"
"TCGA-AA-3979-01A-01R-1022-07"	"TCGA-AA-3979"	"TCGA-AA-3979-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	84	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: af17788e-a562-43aa-bd36-fd3e031f483c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30742///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3979///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3979-01A-01R-1022-07///unique_patient_id: TCGA-AA-3979"
"TCGA-AA-3955-01A-02R-1022-07"	"TCGA-AA-3955"	"TCGA-AA-3955-01A-02R-1022-07"	"tumor"	"co"	NA	NA	"late"	"2"	"2"	"0"	NA	38	NA	NA	NA	NA	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 38///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 5c24435e-8e50-42c2-80c7-919b1cad0133///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -14186///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 31///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2a///pathologic_T: T2///pathologic_stage: Stage IIIB///patient_id: 3955///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3955-01A-02R-1022-07///unique_patient_id: TCGA-AA-3955"
"TCGA-AA-3877-01A-01R-1022-07"	"TCGA-AA-3877"	"TCGA-AA-3877-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"1"	"0"	"0"	NA	83	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 83///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 043a4745-566b-4106-b159-99cb8b394b81///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30377///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T1///pathologic_stage: Stage I///patient_id: 3877///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3877-01A-01R-1022-07///unique_patient_id: TCGA-AA-3877"
"TCGA-AA-3815-01A-01R-1022-07"	"TCGA-AA-3815"	"TCGA-AA-3815-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	65	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: b16bb717-d1cf-4237-a554-43f3995b82f2///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23921///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3815///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.82///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3815-01A-01R-1022-07///unique_patient_id: TCGA-AA-3815"
"TCGA-AA-3866-01A-01R-1022-07"	"TCGA-AA-3866"	"TCGA-AA-3866-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	78	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 02f9668c-71e6-485f-88b1-b37dc8bdd2ab///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28671///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3866///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 11.36///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3866-01A-01R-1022-07///unique_patient_id: TCGA-AA-3866"
"TCGA-AA-3986-01A-02R-1022-07"	"TCGA-AA-3986"	"TCGA-AA-3986-01A-02R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	73	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 04d7a52f-a89b-4114-a608-a6254b4d604f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26967///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 27///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3986///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.89///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3986-01A-02R-1022-07///unique_patient_id: TCGA-AA-3986"
"TCGA-AA-3977-01A-01R-1022-07"	"TCGA-AA-3977"	"TCGA-AA-3977-01A-01R-1022-07"	"tumor"	"co"	NA	NA	NA	"2"	"0"	NA	NA	65	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 33e989b9-fac4-47d8-b429-269044ac772a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23832///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: NA///pathologic_N: N0///pathologic_T: T2///pathologic_stage: NA///patient_id: 3977///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3977-01A-01R-1022-07///unique_patient_id: TCGA-AA-3977"
"TCGA-AA-3872-01A-01R-1022-07"	"TCGA-AA-3872"	"TCGA-AA-3872-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	45	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 45///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 20ccd267-74e5-4574-a8e1-028bcd74aaeb///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -16651///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 29///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 23///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 3872///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3872-01A-01R-1022-07///unique_patient_id: TCGA-AA-3872"
"TCGA-A6-3808-01A-01R-1022-07"	"TCGA-A6-3808"	"TCGA-A6-3808-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	73	NA	NA	NA	"living"	NA	"MSS"	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 4f9775f2-b663-4daf-aa9e-50915cae9407///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26666///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180.3///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 4///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3808///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 84.5///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 0a57e86e-33d6-40cf-b318-94665c630ef9///date_of_form_completion: 2010-10-11///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 278///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-3808-01A-01R-1022-07///unique_patient_id: TCGA-A6-3808"
"TCGA-AA-3984-01A-02R-1022-07"	"TCGA-AA-3984"	"TCGA-AA-3984-01A-02R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	61	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 61///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: db246424-3979-4f23-b316-8d30c449ee15///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22585///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3984///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3984-01A-02R-1022-07///unique_patient_id: TCGA-AA-3984"
"TCGA-AA-3851-01A-01R-1022-07"	"TCGA-AA-3851"	"TCGA-AA-3851-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	74	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 1add38c2-df6f-47c9-9373-0bec0e40baf8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27089///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3851///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 7.55///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3851-01A-01R-1022-07///unique_patient_id: TCGA-AA-3851"
"TCGA-AA-3949-01A-01R-1022-07"	"TCGA-AA-3949"	"TCGA-AA-3949-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	87	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 87///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: cbdabbcd-d8f1-4d7c-9e18-ebd83d888c51///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32080///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 3949///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3949-01A-01R-1022-07///unique_patient_id: TCGA-AA-3949"
"TCGA-AA-3869-01A-01R-1022-07"	"TCGA-AA-3869"	"TCGA-AA-3869-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	76	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 76///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 39d3b5b3-d51e-4d77-a8aa-2977fa734fab///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28062///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 28///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 14///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 3869///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3869-01A-01R-1022-07///unique_patient_id: TCGA-AA-3869"
"TCGA-AA-3855-01A-01R-1022-07"	"TCGA-AA-3855"	"TCGA-AA-3855-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	72	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: b4c3cf95-a27c-4bcf-9321-38723473e83b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26540///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 36///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3855///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3855-01A-01R-1022-07///unique_patient_id: TCGA-AA-3855"
"TCGA-AA-3966-01A-01R-1113-07"	"TCGA-AA-3966"	"TCGA-AA-3966-01A-01R-1113-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	89	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 89///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: bc42fe2d-1a33-428d-a601-b1871f4c8d9b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32537///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3966///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3966-01A-01R-1113-07///unique_patient_id: TCGA-AA-3966"
"TCGA-AY-4070-01A-01R-1113-07"	"TCGA-AY-4070"	"TCGA-AY-4070-01A-01R-1113-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	50	NA	NA	496	"deceased"	NA	NA	"caecum"	"r"	"f"	"wt"	NA	NA	NA	NA	NA	NA	"3"	"black"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 50///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 6baf61b6-ae5b-42f0-adc9-0d26fda231f7///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -18621///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 160///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 4070///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 67.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R1///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AY///tumor_tissue_site: Colon///venous_invasion: YES///weight: 100.8///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: f27453aa-abaa-4a40-8c16-d2ccf73dff51///date_of_form_completion: 2010-11-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 496///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 182///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Dead///Extract.Name: TCGA-AY-4070-01A-01R-1113-07///unique_patient_id: TCGA-AY-4070"
"TCGA-AA-3530-01A-01R-1022-07"	"TCGA-AA-3530"	"TCGA-AA-3530-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	80	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 1ad0b9b9-7ded-4281-b114-9dcc6138c037///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29401///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3530///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.88///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3530-01A-01R-1022-07///unique_patient_id: TCGA-AA-3530"
"TCGA-AA-3952-01A-01R-1022-07"	"TCGA-AA-3952"	"TCGA-AA-3952-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	68	NA	NA	NA	NA	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: c1e141af-bdd1-4176-8c0e-cf1ab0c1d9d3///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24868///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 6///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3952///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3952-01A-01R-1022-07///unique_patient_id: TCGA-AA-3952"
"TCGA-AA-3939-01A-01R-1022-07"	"TCGA-AA-3939"	"TCGA-AA-3939-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	83	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 83///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 81555ac5-9cc2-49ae-9033-657f56243f20///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30439///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 40///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3939///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3939-01A-01R-1022-07///unique_patient_id: TCGA-AA-3939"
"TCGA-AA-3989-01A-01R-1022-07"	"TCGA-AA-3989"	"TCGA-AA-3989-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	84	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: d5619045-060a-4b60-86e4-6a5774994fd4///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30712///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3989///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3989-01A-01R-1022-07///unique_patient_id: TCGA-AA-3989"
"TCGA-AA-3973-01A-01R-1022-07"	"TCGA-AA-3973"	"TCGA-AA-3973-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	69	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: e8841edf-e070-425b-b4d4-bbb2115f9dbd///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25536///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 3973///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 375.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3973-01A-01R-1022-07///unique_patient_id: TCGA-AA-3973"
"TCGA-AA-3968-01A-01R-1022-07"	"TCGA-AA-3968"	"TCGA-AA-3968-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	55	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 55///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: cab7bdbc-0a11-4901-97c3-26b884f79cb5///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -20089///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3968///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.55///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3968-01A-01R-1022-07///unique_patient_id: TCGA-AA-3968"
"TCGA-AA-3846-01A-01R-1022-07"	"TCGA-AA-3846"	"TCGA-AA-3846-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	74	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: f2ef5afa-6191-43a1-a023-d53c0d985139///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27057///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3846///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3846-01A-01R-1022-07///unique_patient_id: TCGA-AA-3846"
"TCGA-AA-3821-01A-01R-1022-07"	"TCGA-AA-3821"	"TCGA-AA-3821-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	81	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 0e87e5fd-d5bb-4c0d-952d-711a6abbf336///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29706///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3821///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.14///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3821-01A-01R-1022-07///unique_patient_id: TCGA-AA-3821"
"TCGA-AA-3861-01A-01R-1022-07"	"TCGA-AA-3861"	"TCGA-AA-3861-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	72	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 5da56982-6de7-4994-aa9e-3b01200b2959///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26601///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3861///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3861-01A-01R-1022-07///unique_patient_id: TCGA-AA-3861"
"TCGA-AY-4071-01A-01R-1113-07"	"TCGA-AY-4071"	"TCGA-AY-4071-01A-01R-1113-07"	"tumor"	NA	NA	NA	"early"	"1"	"0"	"0"	NA	63	NA	NA	29	"deceased"	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: NA///b_symptoms: NA///bcr_patient_uuid: 315ef7f6-ca21-4d87-8f19-40bd455885ec///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -23320///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: NA///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 25///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: NA///pathologic_N: N0///pathologic_T: T1///pathologic_stage: Stage I///patient_id: 4071///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: AY///tumor_tissue_site: NA///venous_invasion: NO///weight: 113.7///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 4fb84d41-5c59-47e8-a4a2-025ed838701f///date_of_form_completion: 2011-4-7///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 29///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-AY-4071-01A-01R-1113-07///unique_patient_id: TCGA-AY-4071"
"TCGA-AA-3862-01A-01R-1022-07"	"TCGA-AA-3862"	"TCGA-AA-3862-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	82	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 05ff79c5-1127-4cac-8f4c-84089a3f2cde///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30162///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3862///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3862-01A-01R-1022-07///unique_patient_id: TCGA-AA-3862"
"TCGA-AA-3870-01A-01R-1022-07"	"TCGA-AA-3870"	"TCGA-AA-3870-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	71	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: beb63625-d9bf-4ccd-bc53-635b53d24240///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26085///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3870///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3870-01A-01R-1022-07///unique_patient_id: TCGA-AA-3870"
"TCGA-AA-3970-01A-01R-1022-07"	"TCGA-AA-3970"	"TCGA-AA-3970-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	65	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 733d8b6a-ca9d-4a69-8c9c-1f88733e8b68///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23741///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 27///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3970///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3970-01A-01R-1022-07///unique_patient_id: TCGA-AA-3970"
"TCGA-AA-3844-01A-01R-1022-07"	"TCGA-AA-3844"	"TCGA-AA-3844-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	78	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 4f786107-3cf5-4ab3-bba4-f399dee23f0e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28521///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 7///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3844///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3844-01A-01R-1022-07///unique_patient_id: TCGA-AA-3844"
"TCGA-AA-3941-01A-01R-1022-07"	"TCGA-AA-3941"	"TCGA-AA-3941-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	84	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 835c3e23-ac2b-4bc9-ac65-e3e81adecf77///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -31015///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 41///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1a///pathologic_N: N1b///pathologic_T: T4///pathologic_stage: Stage IVA///patient_id: 3941///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3941-01A-01R-1022-07///unique_patient_id: TCGA-AA-3941"
"TCGA-AA-3842-01A-01R-1022-07"	"TCGA-AA-3842"	"TCGA-AA-3842-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"2"	"1"	"0"	NA	51	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 80311cf5-7e18-4545-92ad-c4b7dd5c9677///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -18842///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T2///pathologic_stage: Stage IIIA///patient_id: 3842///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3842-01A-01R-1022-07///unique_patient_id: TCGA-AA-3842"
"TCGA-AA-3950-01A-02R-1022-07"	"TCGA-AA-3950"	"TCGA-AA-3950-01A-02R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	79	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 79///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: cc53bf9e-5e27-4305-a08b-552120c10aa5///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29130///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 2///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3950///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3950-01A-02R-1022-07///unique_patient_id: TCGA-AA-3950"
"TCGA-AA-3710-01A-01R-1022-07"	"TCGA-AA-3710"	"TCGA-AA-3710-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	80	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: f5c3bc61-1018-4351-bb23-aacc1459365f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29465///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3710///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.12///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3710-01A-01R-1022-07///unique_patient_id: TCGA-AA-3710"
"TCGA-A6-3809-01A-01R-1022-07"	"TCGA-A6-3809"	"TCGA-A6-3809-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"0"	NA	71	NA	NA	NA	"living"	NA	"MSI"	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 8632579e-d318-4dab-9994-d3945afc42ab///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -26274///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 160///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 5///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T4///pathologic_stage: Stage IIB///patient_id: 3809///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 102.1///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c8e553a4-b76e-48a2-9de6-8e88babbf880///date_of_form_completion: 2010-10-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 313///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-3809-01A-01R-1022-07///unique_patient_id: TCGA-A6-3809"
"TCGA-AA-3971-01A-01R-1022-07"	"TCGA-AA-3971"	"TCGA-AA-3971-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	58	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 58///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 10994156-7c2f-420e-aeb8-11d566b3d5e4///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -21518///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3971///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.48///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3971-01A-01R-1022-07///unique_patient_id: TCGA-AA-3971"
"TCGA-AA-3867-01A-01R-1022-07"	"TCGA-AA-3867"	"TCGA-AA-3867-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	74	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: d655bbf6-c710-411d-aff5-ceb0fb6e6680///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27028///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 4///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3867///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 304.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3867-01A-01R-1022-07///unique_patient_id: TCGA-AA-3867"
"TCGA-AA-3980-01A-02R-1022-07"	"TCGA-AA-3980"	"TCGA-AA-3980-01A-02R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	89	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 89///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 384400c1-98d6-4cc3-8724-de6711f6208b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32630///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3980///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3980-01A-02R-1022-07///unique_patient_id: TCGA-AA-3980"
"TCGA-AA-3864-01A-01R-1022-07"	"TCGA-AA-3864"	"TCGA-AA-3864-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	71	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c82bbe23-0264-45a7-b1a6-82b4654108c8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26237///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3864///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.12///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3864-01A-01R-1022-07///unique_patient_id: TCGA-AA-3864"
"TCGA-A6-3807-01A-01R-1022-07"	"TCGA-A6-3807"	"TCGA-A6-3807-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	53	NA	NA	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 53///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 5116e3b4-2bac-40f5-8046-b9c1783faaa5///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -19624///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 163///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3807///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 45///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 109.5///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 0ac8de49-6a23-48b4-af74-8aaf2a64ca09///date_of_form_completion: 2010-10-26///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 332///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-3807-01A-01R-1022-07///unique_patient_id: TCGA-A6-3807"
"TCGA-AA-3994-01A-01R-1113-07"	"TCGA-AA-3994"	"TCGA-AA-3994-01A-01R-1113-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	69	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 750770db-53cf-4021-a8c2-5e0ddb97fef5///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25322///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 3994///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.52///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3994-01A-01R-1113-07///unique_patient_id: TCGA-AA-3994"
"TCGA-AA-3956-01A-02R-1022-07"	"TCGA-AA-3956"	"TCGA-AA-3956-01A-02R-1022-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	65	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 7b47489f-c3cc-4388-b5d7-c7c02790a5f6///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24044///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 36///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3956///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3956-01A-02R-1022-07///unique_patient_id: TCGA-AA-3956"
"TCGA-AA-3947-01A-01R-1022-07"	"TCGA-AA-3947"	"TCGA-AA-3947-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"0"	NA	60	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 654c6f5c-3e5c-49f0-b53f-87cd9797d7c9///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22034///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T4///pathologic_stage: Stage IIB///patient_id: 3947///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3947-01A-01R-1022-07///unique_patient_id: TCGA-AA-3947"
"TCGA-AA-3982-01A-02R-1022-07"	"TCGA-AA-3982"	"TCGA-AA-3982-01A-02R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	75	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 5a195baa-2d05-4273-a7c4-64cc816b0406///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27607///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 3982///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3982-01A-02R-1022-07///unique_patient_id: TCGA-AA-3982"
"TCGA-AA-3972-01A-01R-1022-07"	"TCGA-AA-3972"	"TCGA-AA-3972-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	72	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26360///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3972///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.15///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3972-01A-01R-1022-07///unique_patient_id: TCGA-AA-3972"
"TCGA-AA-3850-01A-01R-1022-07"	"TCGA-AA-3850"	"TCGA-AA-3850-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	74	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 21bdad0d-c6a2-428c-b2b4-0de282b34abc///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27089///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3850///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3850-01A-01R-1022-07///unique_patient_id: TCGA-AA-3850"
"TCGA-AA-3930-01A-01R-1022-07"	"TCGA-AA-3930"	"TCGA-AA-3930-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	66	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 81f6b141-2195-4091-9cd3-dfb022663949///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24321///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 29///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 24///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3930///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3930-01A-01R-1022-07///unique_patient_id: TCGA-AA-3930"
"TCGA-AA-3976-01A-01R-1022-07"	"TCGA-AA-3976"	"TCGA-AA-3976-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"2"	"1"	"0"	NA	70	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 70///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 14efca0c-882d-4fba-b15c-64af6e213b80///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25598///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T2///pathologic_stage: Stage IIIA///patient_id: 3976///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3976-01A-01R-1022-07///unique_patient_id: TCGA-AA-3976"
"TCGA-AA-3811-01A-01R-1022-07"	"TCGA-AA-3811"	"TCGA-AA-3811-01A-01R-1022-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	84	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: d7ebd11a-1339-4b28-be90-a788d2cfa706///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30893///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3811///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3811-01A-01R-1022-07///unique_patient_id: TCGA-AA-3811"
"TCGA-A6-2672-01A-01R-0826-07"	"TCGA-A6-2672"	"TCGA-A6-2672-01A-01R-0826-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	82	NA	NA	NA	"living"	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: b612d491-7442-4119-a53c-5ebcc35c31f4///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -30237///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 157///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 29///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 2672///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 51.5///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: dd848a80-c0fd-4286-887e-9199bc9129e8///date_of_form_completion: 2011-4-12///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 696///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-A6-2672-01A-01R-0826-07///unique_patient_id: TCGA-A6-2672"
"TCGA-AA-3812-01A-01R-0905-07"	"TCGA-AA-3812"	"TCGA-AA-3812-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	82	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 4563e4e0-a661-46de-ad25-9c86a621e147///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29979///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3812///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.52///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3812-01A-01R-0905-07///unique_patient_id: TCGA-AA-3812"
"TCGA-AA-3858-01A-01R-0905-07"	"TCGA-AA-3858"	"TCGA-AA-3858-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	67	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 67///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 44c2854e-3f8c-48e1-b4d5-1b5778d4fce4///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24806///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3858///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3858-01A-01R-0905-07///unique_patient_id: TCGA-AA-3858"
"TCGA-AA-3875-01A-01R-0905-07"	"TCGA-AA-3875"	"TCGA-AA-3875-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"1"	"0"	"0"	NA	78	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 5498d5ef-ad24-4034-9750-7c996c5355e1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28639///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 31///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T1///pathologic_stage: Stage I///patient_id: 3875///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.87///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3875-01A-01R-0905-07///unique_patient_id: TCGA-AA-3875"
"TCGA-AA-3695-01A-01R-0905-07"	"TCGA-AA-3695"	"TCGA-AA-3695-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	63	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 23d0681a-912a-408f-b19a-0bbcf5ffc2f3///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23164///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 33///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 6///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3695///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3695-01A-01R-0905-07///unique_patient_id: TCGA-AA-3695"
"TCGA-AA-3679-01A-02R-0905-07"	"TCGA-AA-3679"	"TCGA-AA-3679-01A-02R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	59	NA	NA	NA	NA	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 59///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: d17a2ab0-faef-40de-a87d-1291868b200d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -21611///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3679///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 25.78///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3679-01A-02R-0905-07///unique_patient_id: TCGA-AA-3679"
"TCGA-AA-3672-01A-01R-0905-07"	"TCGA-AA-3672"	"TCGA-AA-3672-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	90	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 90///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: c46971a1-cbac-425d-bac2-f4142c92522e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32872///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 4///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3672///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.27///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3672-01A-01R-0905-07///unique_patient_id: TCGA-AA-3672"
"TCGA-AA-3667-01A-01R-0905-07"	"TCGA-AA-3667"	"TCGA-AA-3667-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	36	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 36///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: d651f9ba-8746-46c4-852c-6c2992c7d10e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -13302///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3667///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.45///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3667-01A-01R-0905-07///unique_patient_id: TCGA-AA-3667"
"TCGA-AA-3664-01A-01R-0905-07"	"TCGA-AA-3664"	"TCGA-AA-3664-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	74	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: a06c09a8-0951-49f4-a765-5147bbcae109///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27362///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3664///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 4.22///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3664-01A-01R-0905-07///unique_patient_id: TCGA-AA-3664"
"TCGA-AA-3831-01A-01R-0905-07"	"TCGA-AA-3831"	"TCGA-AA-3831-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	66	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: bce5579c-08c6-48e9-853e-fac85ba8cbea///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24410///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3831///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3831-01A-01R-0905-07///unique_patient_id: TCGA-AA-3831"
"TCGA-AA-3684-01A-02R-0905-07"	"TCGA-AA-3684"	"TCGA-AA-3684-01A-02R-0905-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	65	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: d761bc06-dee8-478a-be99-8af9c504e49c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23741///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 10///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 9///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 3684///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.28///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3684-01A-02R-0905-07///unique_patient_id: TCGA-AA-3684"
"TCGA-AA-3693-01A-01R-0905-07"	"TCGA-AA-3693"	"TCGA-AA-3693-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	77	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 33522271-b2ca-4da4-a942-501ab9117c51///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28459///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 3693///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.42///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3693-01A-01R-0905-07///unique_patient_id: TCGA-AA-3693"
"TCGA-AA-3675-01A-02R-0905-07"	"TCGA-AA-3675"	"TCGA-AA-3675-01A-02R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	84	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 41658cf8-0de1-4a97-bb60-0f0107c84e00///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30800///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3675///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.06///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3675-01A-02R-0905-07///unique_patient_id: TCGA-AA-3675"
"TCGA-AA-3681-01A-01R-0905-07"	"TCGA-AA-3681"	"TCGA-AA-3681-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	77	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: abb0d53f-f74e-45dc-8fbb-40863016f3c6///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28399///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3681///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.36///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3681-01A-01R-0905-07///unique_patient_id: TCGA-AA-3681"
"TCGA-AA-3818-01A-01R-0905-07"	"TCGA-AA-3818"	"TCGA-AA-3818-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	78	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: fdffda5f-72b2-4153-b7f1-d7043b7ca898///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28762///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3818///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.79///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3818-01A-01R-0905-07///unique_patient_id: TCGA-AA-3818"
"TCGA-AA-3685-01A-02R-0905-07"	"TCGA-AA-3685"	"TCGA-AA-3685-01A-02R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	69	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: dca004bf-9c14-45a1-b186-ab3759f6c7fe///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25506///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3685///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 8.76///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3685-01A-02R-0905-07///unique_patient_id: TCGA-AA-3685"
"TCGA-AA-3680-01A-01R-0905-07"	"TCGA-AA-3680"	"TCGA-AA-3680-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	67	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 67///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: f3b9defb-88ed-4c95-9feb-7197d869676c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24655///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 35///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 12///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 3680///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 59.94///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3680-01A-01R-0905-07///unique_patient_id: TCGA-AA-3680"
"TCGA-AA-3688-01A-01R-0905-07"	"TCGA-AA-3688"	"TCGA-AA-3688-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	80	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 2c9996bb-af6e-4424-881a-e81b9c9aeb78///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29219///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3688///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 47.45///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3688-01A-01R-0905-07///unique_patient_id: TCGA-AA-3688"
"TCGA-AA-3856-01A-01R-0905-07"	"TCGA-AA-3856"	"TCGA-AA-3856-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	59	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 59///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 0b8de222-119a-40f3-8beb-12b9d933225b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -21669///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3856///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3856-01A-01R-0905-07///unique_patient_id: TCGA-AA-3856"
"TCGA-AA-3841-01A-01R-0905-07"	"TCGA-AA-3841"	"TCGA-AA-3841-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	66	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 7dfbc0ed-e684-4966-8b59-fb6b9e80c129///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24230///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3841///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3841-01A-01R-0905-07///unique_patient_id: TCGA-AA-3841"
"TCGA-AA-3852-01A-01R-0905-07"	"TCGA-AA-3852"	"TCGA-AA-3852-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	88	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 88///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 6fc5e56a-1f5e-4ff1-948e-5ef636ebb48d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32202///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3852///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3852-01A-01R-0905-07///unique_patient_id: TCGA-AA-3852"
"TCGA-AA-3833-01A-01R-0905-07"	"TCGA-AA-3833"	"TCGA-AA-3833-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	63	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 1a09207e-9184-4f32-bd07-a9f4dc6c825d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23010///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3833///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3833-01A-01R-0905-07///unique_patient_id: TCGA-AA-3833"
"TCGA-AA-3696-01A-01R-0905-07"	"TCGA-AA-3696"	"TCGA-AA-3696-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	75	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: aa909ffb-03e1-4e3f-8888-2212b23d90b7///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -27666///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 26///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3696///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3696-01A-01R-0905-07///unique_patient_id: TCGA-AA-3696"
"TCGA-AA-3848-01A-01R-0905-07"	"TCGA-AA-3848"	"TCGA-AA-3848-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	82	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 0a815133-0edd-4422-89f2-2f067b6f2156///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30194///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 6///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3848///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3848-01A-01R-0905-07///unique_patient_id: TCGA-AA-3848"
"TCGA-AA-3837-01A-01R-0905-07"	"TCGA-AA-3837"	"TCGA-AA-3837-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	67	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 67///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 0f940ec0-eb0b-422a-a764-a26c8e5c216d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24655///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 36///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 2///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3837///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3837-01A-01R-0905-07///unique_patient_id: TCGA-AA-3837"
"TCGA-AA-3854-01A-01R-0905-07"	"TCGA-AA-3854"	"TCGA-AA-3854-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	71	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 7a6c54f1-f4e4-426b-b306-2ca3c4de12ca///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26021///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3854///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3854-01A-01R-0905-07///unique_patient_id: TCGA-AA-3854"
"TCGA-AA-3678-01A-01R-0905-07"	"TCGA-AA-3678"	"TCGA-AA-3678-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"2"	"1"	"0"	NA	60	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: c616f95f-4ea1-4019-8c17-041878085c88///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22219///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 26///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T2///pathologic_stage: Stage III///patient_id: 3678///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3678-01A-01R-0905-07///unique_patient_id: TCGA-AA-3678"
"TCGA-AA-3715-01A-01R-0905-07"	"TCGA-AA-3715"	"TCGA-AA-3715-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	77	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: e394e9ec-7288-4ede-9ef8-41b631d100dd///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28428///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3715///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 7.05///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3715-01A-01R-0905-07///unique_patient_id: TCGA-AA-3715"
"TCGA-AA-3692-01A-01R-0905-07"	"TCGA-AA-3692"	"TCGA-AA-3692-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	47	NA	NA	NA	NA	NA	NA	"splenicflexure"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 47///anatomic_neoplasm_subdivision: Splenic Flexure///b_symptoms: NA///bcr_patient_uuid: bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -17167///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 30///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3692///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 49.21///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3692-01A-01R-0905-07///unique_patient_id: TCGA-AA-3692"
"TCGA-AA-3819-01A-01R-0905-07"	"TCGA-AA-3819"	"TCGA-AA-3819-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	41	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 41///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 192da41f-f0a5-494e-8eb9-96bcdae56ff8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -15280///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3819///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.28///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3819-01A-01R-0905-07///unique_patient_id: TCGA-AA-3819"
"TCGA-AA-3673-01A-01R-0905-07"	"TCGA-AA-3673"	"TCGA-AA-3673-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	53	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 53///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 628408ce-0691-4e0b-b4c7-aca9a0d73bb0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -19509///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 41///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3673///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.89///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3673-01A-01R-0905-07///unique_patient_id: TCGA-AA-3673"
"TCGA-AA-3814-01A-01R-0905-07"	"TCGA-AA-3814"	"TCGA-AA-3814-01A-01R-0905-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	85	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 85///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: f38d49b7-6cad-4460-abd0-3685a3b2d941///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -31380///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3814///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 4.03///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3814-01A-01R-0905-07///unique_patient_id: TCGA-AA-3814"
"TCGA-AA-3860-01A-02R-0905-07"	"TCGA-AA-3860"	"TCGA-AA-3860-01A-02R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	53	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 53///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: ac6a3df9-41b1-4e5a-a15e-f44481384c23///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -19448///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 3860///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3860-01A-02R-0905-07///unique_patient_id: TCGA-AA-3860"
"TCGA-AA-3666-01A-02R-0905-07"	"TCGA-AA-3666"	"TCGA-AA-3666-01A-02R-0905-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	68	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: a512701f-88bb-4b05-8c94-fd285b9dd13e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25019///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 41///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3666///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 41.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3666-01A-02R-0905-07///unique_patient_id: TCGA-AA-3666"
"TCGA-AA-3544-01A-01R-0821-07"	"TCGA-AA-3544"	"TCGA-AA-3544-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	68	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: e831369c-78c0-4c75-9cf3-f46ed669312e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24958///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3544///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.39///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3544-01A-01R-0821-07///unique_patient_id: TCGA-AA-3544"
"TCGA-AA-3522-01A-01R-0821-07"	"TCGA-AA-3522"	"TCGA-AA-3522-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	67	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 67///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: d7ba64d7-b4e5-488d-9f28-bcb7bf3c0f35///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24653///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3522///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.96///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3522-01A-01R-0821-07///unique_patient_id: TCGA-AA-3522"
"TCGA-AA-3553-01A-01R-0821-07"	"TCGA-AA-3553"	"TCGA-AA-3553-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	61	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 61///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: d181c72b-843c-4b2d-b014-2a6dd1c3c1ec///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22523///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3553///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3553-01A-01R-0821-07///unique_patient_id: TCGA-AA-3553"
"TCGA-AA-3556-01A-01R-0821-07"	"TCGA-AA-3556"	"TCGA-AA-3556-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	78	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: fd16b634-2e04-44a3-862d-fb03cd73c057///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28703///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: NA///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3556///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3556-01A-01R-0821-07///unique_patient_id: TCGA-AA-3556"
"TCGA-AA-3524-01A-02R-0821-07"	"TCGA-AA-3524"	"TCGA-AA-3524-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	85	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 85///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 03efbc94-a43d-4db0-9377-e397348430a6///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -31196///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 28///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3524///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3524-01A-02R-0821-07///unique_patient_id: TCGA-AA-3524"
"TCGA-AA-3561-01A-01R-0821-07"	"TCGA-AA-3561"	"TCGA-AA-3561-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	72	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 01ad5016-f691-4bca-82a0-910429d8d25b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26420///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 50///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3561///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3561-01A-01R-0821-07///unique_patient_id: TCGA-AA-3561"
"TCGA-AA-3555-01A-01R-0821-07"	"TCGA-AA-3555"	"TCGA-AA-3555-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	81	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 36eaf209-c332-4321-b6aa-51a3368ecd79///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29617///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 26///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3555///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3555-01A-01R-0821-07///unique_patient_id: TCGA-AA-3555"
"TCGA-AA-3542-01A-02R-0821-07"	"TCGA-AA-3542"	"TCGA-AA-3542-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	69	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 9dcb4e16-b582-4cd0-87cf-04f480ec2cec///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25323///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 4///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3542///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.93///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3542-01A-02R-0821-07///unique_patient_id: TCGA-AA-3542"
"TCGA-AA-3526-01A-02R-0821-07"	"TCGA-AA-3526"	"TCGA-AA-3526-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	57	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 57///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 88e64f45-adc4-4223-9838-4d7d45b8f0c0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -21123///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 2///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3526///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.06///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3526-01A-02R-0821-07///unique_patient_id: TCGA-AA-3526"
"TCGA-AA-3531-01A-01R-0821-07"	"TCGA-AA-3531"	"TCGA-AA-3531-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	75	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 401a37f3-6630-4400-a811-a262351e37de///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27513///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 37///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3531///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.65///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3531-01A-01R-0821-07///unique_patient_id: TCGA-AA-3531"
"TCGA-AA-3538-01A-01R-0821-07"	"TCGA-AA-3538"	"TCGA-AA-3538-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	54	NA	NA	NA	NA	NA	NA	"descending"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 54///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: c594196e-49ef-4195-a6b6-4ef4a1d9ec15///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -19752///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 26///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3538///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.84///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3538-01A-01R-0821-07///unique_patient_id: TCGA-AA-3538"
"TCGA-AA-3552-01A-01R-0821-07"	"TCGA-AA-3552"	"TCGA-AA-3552-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	85	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 85///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 265d7b06-65fe-42c5-ad21-e6b160e94718///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -31289///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 10///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3552///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.71///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3552-01A-01R-0821-07///unique_patient_id: TCGA-AA-3552"
"TCGA-A6-2683-01A-01R-0821-07"	"TCGA-A6-2683"	"TCGA-A6-2683-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"1"	NA	57	NA	NA	504	"deceased"	NA	"MSS"	"ascending"	"r"	"f"	"mutant"	NA	NA	NA	NA	NA	NA	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 57///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: fafd4576-0709-49e1-926f-ad1ee09907ec///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -20871///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 166.3///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 12///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 25///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 4///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M1///pathologic_N: N0///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 2683///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2614///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 57.5///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: dfbc2156-2077-4676-8204-c186608390fd///date_of_form_completion: 2011-4-12///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 504///days_to_last_followup: 504///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Dead///Extract.Name: TCGA-A6-2683-01A-01R-0821-07///unique_patient_id: TCGA-A6-2683"
"TCGA-AA-3519-01A-02R-0821-07"	"TCGA-AA-3519"	"TCGA-AA-3519-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	63	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 09942e9f-c178-44bc-9cd9-f5bfa350b23f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23131///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 43///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3519///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.26///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3519-01A-02R-0821-07///unique_patient_id: TCGA-AA-3519"
"TCGA-AA-3521-01A-01R-0821-07"	"TCGA-AA-3521"	"TCGA-AA-3521-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	87	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 87///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: ad440651-a2de-4bb1-90da-1e5e8975ab59///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -31805///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3521///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.99///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3521-01A-01R-0821-07///unique_patient_id: TCGA-AA-3521"
"TCGA-AA-3548-01A-01R-0821-07"	"TCGA-AA-3548"	"TCGA-AA-3548-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	71	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 2dced66c-1f0d-4039-a5e5-54cca77c16e9///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26174///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 4///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3548///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 55.01///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3548-01A-01R-0821-07///unique_patient_id: TCGA-AA-3548"
"TCGA-AA-3514-01A-02R-0821-07"	"TCGA-AA-3514"	"TCGA-AA-3514-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	81	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: ddf69ed9-4c53-48b8-9f01-495bd60c3425///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29738///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3514///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3514-01A-02R-0821-07///unique_patient_id: TCGA-AA-3514"
"TCGA-AA-3558-01A-01R-0821-07"	"TCGA-AA-3558"	"TCGA-AA-3558-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	70	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 70///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: a56d528b-238a-4556-92c8-7645304a2da0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25752///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 46///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3558///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3558-01A-01R-0821-07///unique_patient_id: TCGA-AA-3558"
"TCGA-AA-3520-01A-01R-0821-07"	"TCGA-AA-3520"	"TCGA-AA-3520-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	86	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 86///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 5f1399ef-8100-49e7-806f-9f532e55c0ba///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -31531///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3520///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3520-01A-01R-0821-07///unique_patient_id: TCGA-AA-3520"
"TCGA-AA-3549-01A-02R-0821-07"	"TCGA-AA-3549"	"TCGA-AA-3549-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	69	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: e6ec5a68-7555-4f26-bd7e-9cdb4c5f7004///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25414///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 31///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3549///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.76///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3549-01A-02R-0821-07///unique_patient_id: TCGA-AA-3549"
"TCGA-AA-3562-01A-02R-0821-07"	"TCGA-AA-3562"	"TCGA-AA-3562-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	82	NA	NA	NA	NA	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 127f738d-afa1-42f6-a9a0-f33806667b84///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30254///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 28///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 7///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3562///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3562-01A-02R-0821-07///unique_patient_id: TCGA-AA-3562"
"TCGA-AA-3532-01A-01R-0821-07"	"TCGA-AA-3532"	"TCGA-AA-3532-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	63	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: aa85d9e8-caa6-422c-95ce-780e4ac2a5e4///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23133///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 35///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3532///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.28///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3532-01A-01R-0821-07///unique_patient_id: TCGA-AA-3532"
"TCGA-A6-2670-01A-02R-0821-07"	"TCGA-A6-2670"	"TCGA-A6-2670-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	45	NA	NA	774	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 45///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 65bb7520-f055-43a8-b735-1152fa2c9e04///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -16512///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: 423///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 175.3///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 2670///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 90.9///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 902F565A-18FE-4F7D-B0DC-BBCA7C91A821///date_of_form_completion: 2011-5-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 774///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: LIVING///Extract.Name: TCGA-A6-2670-01A-02R-0821-07///unique_patient_id: TCGA-A6-2670"
"TCGA-A6-2677-01A-01R-0821-07"	"TCGA-A6-2677"	"TCGA-A6-2677-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	68	NA	NA	740	"deceased"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: d976782c-90c1-421d-b83c-7fc2617e2709///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25143///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 160///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 30///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 2///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 2677///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 27.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 55.2///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: abc264a9-4b23-4e56-a33a-f78aefda81a8///date_of_form_completion: 2011-6-6///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 740///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Dead///Extract.Name: TCGA-A6-2677-01A-01R-0821-07///unique_patient_id: TCGA-A6-2677"
"TCGA-AA-3560-01A-01R-0821-07"	"TCGA-AA-3560"	"TCGA-AA-3560-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	72	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 2d02bd7a-5beb-4e43-9ccb-18d89c9d5ca2///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26359///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 25///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3560///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3560-01A-01R-0821-07///unique_patient_id: TCGA-AA-3560"
"TCGA-AA-3529-01A-02R-0821-07"	"TCGA-AA-3529"	"TCGA-AA-3529-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	78	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: bfb07784-693b-4c25-874e-4ad6e04a5d46///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28608///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 34///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 10///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 3529///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 17.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3529-01A-02R-0821-07///unique_patient_id: TCGA-AA-3529"
"TCGA-A6-2678-01A-01R-0821-07"	"TCGA-A6-2678"	"TCGA-A6-2678-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	43	NA	NA	NA	"living"	NA	"MSS"	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 43///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 3a785e32-7960-4c72-84c4-fb42c4dd86f1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -16030///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 171///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 26///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: 4///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 2678///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 13.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 96.1///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3947cf97-fbd6-4e18-9f7a-f3c8e180acdb///date_of_form_completion: 2011-8-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 781///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-A6-2678-01A-01R-0821-07///unique_patient_id: TCGA-A6-2678"
"TCGA-AA-3534-01A-01R-0821-07"	"TCGA-AA-3534"	"TCGA-AA-3534-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	78	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: df228c56-89ac-4122-93b3-6c0740c4ec09///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28488///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 36///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3534///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.56///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3534-01A-01R-0821-07///unique_patient_id: TCGA-AA-3534"
"TCGA-A6-2674-01A-02R-0821-07"	"TCGA-A6-2674"	"TCGA-A6-2674-01A-02R-0821-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	71	NA	NA	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"4"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 57cdaa1c-4e94-4a28-ab3b-300c0457555f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26291///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 175.2///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 7///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 2674///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 32.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 85.6///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: cae99ff9-b20e-4d09-aeb6-646a4c39926e///date_of_form_completion: 2011-5-9///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 761///days_to_new_tumor_event_after_initial_treatment: 735///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-A6-2674-01A-02R-0821-07///unique_patient_id: TCGA-A6-2674"
"TCGA-AA-3527-01A-01R-0821-07"	"TCGA-AA-3527"	"TCGA-AA-3527-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	90	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 90///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 269e8ca8-722d-449b-ace1-6545bd72bdd6///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32872///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3527///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 4.72///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3527-01A-01R-0821-07///unique_patient_id: TCGA-AA-3527"
"TCGA-AA-3517-01A-01R-0821-07"	"TCGA-AA-3517"	"TCGA-AA-3517-01A-01R-0821-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	60	NA	NA	NA	NA	NA	NA	"splenicflexure"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Splenic Flexure///b_symptoms: NA///bcr_patient_uuid: c4d74653-d26b-4e51-aee0-82ee3d42f883///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22099///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 54///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3517///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.23///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3517-01A-01R-0821-07///unique_patient_id: TCGA-AA-3517"
"TCGA-AA-3543-01A-01R-0826-07"	"TCGA-AA-3543"	"TCGA-AA-3543-01A-01R-0826-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	84	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 912b61a1-6a5b-451c-b753-9c3dac03e8cb///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30771///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: Yes///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 25///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3543///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.81///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3543-01A-01R-0826-07///unique_patient_id: TCGA-AA-3543"
"TCGA-AA-3554-01A-01R-0826-07"	"TCGA-AA-3554"	"TCGA-AA-3554-01A-01R-0826-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	62	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 62///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: ba49b428-246d-46d2-b549-39a5fc8f7003///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22798///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: Yes///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 39///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 3///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3554///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3554-01A-01R-0826-07///unique_patient_id: TCGA-AA-3554"
"TCGA-AA-3525-01A-02R-0826-07"	"TCGA-AA-3525"	"TCGA-AA-3525-01A-02R-0826-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	90	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 90///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: b107565b-7558-4745-952b-689178367e1c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32872///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 28///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 3525///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 11.14///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3525-01A-02R-0826-07///unique_patient_id: TCGA-AA-3525"
"TCGA-A6-2676-01A-01R-0826-07"	"TCGA-A6-2676"	"TCGA-A6-2676-01A-01R-0826-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"0"	NA	75	NA	NA	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 89a6384e-1cea-440b-9f17-d57cb0805174///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -27402///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 154.9///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T4///pathologic_stage: Stage IIB///patient_id: 2676///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 6.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 45.9///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 7f3bf831-9ff0-47a0-be5d-7a46ea690284///date_of_form_completion: 2011-4-22///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 711///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-A6-2676-01A-01R-0826-07///unique_patient_id: TCGA-A6-2676"
"TCGA-AA-3518-01A-02R-0826-07"	"TCGA-AA-3518"	"TCGA-AA-3518-01A-02R-0826-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	81	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c5c4a0a5-900d-483d-9282-475654d63265///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29769///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 27///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3518///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.48///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3518-01A-02R-0826-07///unique_patient_id: TCGA-AA-3518"
"TCGA-AA-3516-01A-02R-0826-07"	"TCGA-AA-3516"	"TCGA-AA-3516-01A-02R-0826-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	74	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: d9d7f0d4-fa64-48f2-8037-52cbf0b34ad8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27303///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: Yes///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 26///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 7///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3516///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.41///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3516-01A-02R-0826-07///unique_patient_id: TCGA-AA-3516"
"TCGA-A6-2679-11A-01R-1758-07"	"TCGA-A6-2679"	"TCGA-A6-2679-11A-01R-1758-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	73	NA	NA	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 0f74d992-00da-4728-9564-086ca1b95921///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26819///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 165.1///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: NA///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIB///patient_id: 2679///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 15.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 65.9///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c294c817-ccca-40e8-a8c3-a285e1dae95b///date_of_form_completion: 2011-8-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 778///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-2679-11A-01R-1758-07///unique_patient_id: TCGA-A6-2679"
"TCGA-A6-2685-11A-01R-1758-07"	"TCGA-A6-2685"	"TCGA-A6-2685-11A-01R-1758-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	48	NA	NA	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	NA	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 48///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: e5921d6b-51cf-44be-b295-610cf7c3a69a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -17756///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 171///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 29///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: NA///patient_id: 2685///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 29.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 77.3///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 061b693d-55d3-4f32-8a1e-0c6c107ce80c///date_of_form_completion: 2011-2-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 464///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-2685-11A-01R-1758-07///unique_patient_id: TCGA-A6-2685"
"TCGA-A6-2682-11A-01R-1758-07"	"TCGA-A6-2682"	"TCGA-A6-2682-11A-01R-1758-07"	"adjacentnormal"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	70	NA	NA	424	"deceased"	NA	NA	"caecum"	"r"	"m"	"mutant"	NA	NA	NA	NA	NA	NA	"4"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 70///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 77a44132-af22-4115-9fa2-78f2f74bf687///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25682///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 12///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T4b///pathologic_stage: Stage IV///patient_id: 2682///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 96.5///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 9a6eede3-4bca-4aab-afad-6f2fe8c79211///date_of_form_completion: 2011-2-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 424///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 381///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: DECEASED///Extract.Name: TCGA-A6-2682-11A-01R-1758-07///unique_patient_id: TCGA-A6-2682"
"TCGA-A6-2684-11A-01R-1758-07"	"TCGA-A6-2684"	"TCGA-A6-2684-11A-01R-1758-07"	"adjacentnormal"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	75	NA	NA	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 49929108-023e-4d35-b26d-50ab4d3ae581///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -27708///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 163///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 33///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 2684///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 70.1///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: a2305654-87da-4065-ba07-a491bdefd6d9///date_of_form_completion: 2011-1-24///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 387///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-2684-11A-01R-1758-07///unique_patient_id: TCGA-A6-2684"
"TCGA-A6-2671-11A-01R-1758-07"	"TCGA-A6-2671"	"TCGA-A6-2671-11A-01R-1758-07"	"adjacentnormal"	"co"	NA	NA	"late"	"3"	NA	"1"	NA	85	NA	NA	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	NA	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 85///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 565e2726-4942-4726-89d3-c5e3797f7204///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -31329///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 182.8///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 27///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: NA///pathologic_T: T3///pathologic_stage: NA///patient_id: 2671///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 17.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 67.2///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: c98c8bc5-6e58-473e-9b4c-887e478e2ebc///date_of_form_completion: 2012-4-23///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1125///days_to_new_tumor_event_after_initial_treatment: 829///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-A6-2671-11A-01R-1758-07///unique_patient_id: TCGA-A6-2671"
"TCGA-A6-2680-11A-01R-1758-07"	"TCGA-A6-2680"	"TCGA-A6-2680-11A-01R-1758-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	72	NA	NA	NA	"living"	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: ff1407c6-9174-4bae-a19b-d34ca71b898c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26532///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 151///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 34///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 2680///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 52.6///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 10570a72-fe22-4812-aa6e-990446bce5b9///date_of_form_completion: 2011-6-10///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 704///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-A6-2680-11A-01R-1758-07///unique_patient_id: TCGA-A6-2680"
"TCGA-A6-2686-11A-01R-1758-07"	"TCGA-A6-2686"	"TCGA-A6-2686-11A-01R-1758-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	81	NA	NA	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	NA	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 19d1a5fc-3ce9-4e43-a364-a4150bcf911b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -29623///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 155///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 33///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: NA///patient_id: 2686///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 61.4///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 2018bb65-adee-4393-b81b-62fab11c2bcb///date_of_form_completion: 2011-1-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 488///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-2686-11A-01R-1758-07///unique_patient_id: TCGA-A6-2686"
